Pharmaceutical Press Releaseshttp://www.pharmiweb.com/Press Releases in the Pharmaceutical Industry. News, Jobs and Resources at PharmiWeb.comen-gb&#169; 1998 - 2010 PharmiWeb Solutions - All Rights ReservedSun, 20 Mar 2010 01:00:00 GMTPharmiWeb.comhttp://www.pharmiweb.com/images/logos/pweb_logo.gifhttp://www.Pharmiweb.com20http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18379Thermo Fisher Scientific Equips the Scottish Metabolomics Facility with Cutting-Edge Technology to Advance the Field of Metabolomics<strong>Thermo Fisher Scientific Equips the Scottish Metabolomics Facility with Cutting-Edge Technology to Advance the Field of Metabolomics</strong><...<br />Thermo Fisher Scientifichttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18379Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18378Numerical Algorithms Group Marks 40th Anniversary by Expanding the NAG Student Awards Program<strong>Numerical Algorithms Group Marks 40th Anniversary by Expanding the NAG Student Awards Program</strong><br /> The Numerical Algorithms Group ...<br />Numerical Algorithms Grouphttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18378Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18377Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers<strong>Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers</strong><br />PR NewswireCAMBRIDGE, England, March 19, ...<br />Mundipharmahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18377Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18371Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at the Barclays Capital Healthcare Conference<strong>Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at the Barclays Capital Healthcare Conference</strong><br /> Huma...<br />Human Genome Sciences Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18371Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18370Baxter International First Quarter 2010 Financial Results Conference Call<strong>Baxter International First Quarter 2010 Financial Results Conference Call</strong><br /> Baxter International (NYSE:BAX) will host a quarterly...<br />Baxter International Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18370Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18369Synergy Pharmaceuticals Initiates Phase IIa Clinical Trial of SP-304 in Patients with Chronic Constipation<strong>Synergy Pharmaceuticals Initiates Phase IIa Clinical Trial of SP-304 in Patients with Chronic Constipation</strong><br /> Synergy Pharmaceutic...<br />Synergy Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18369Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18368SYSPRO ERP Choice of Leading Pharmaceutical Company<strong>SYSPRO ERP Choice of Leading Pharmaceutical Company</strong><br /> SYSPRO, the leading provider of visionary, pragmatic ERP software, today a...<br />SYSPROhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18368Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18367Nobel Prize Winner Dr. Eric Kandel Joins NeuroFocus Advisory Board<strong>Nobel Prize Winner Dr. Eric Kandel Joins NeuroFocus Advisory Board</strong><br />- Columbia University Professor and Noble Laureate for His Co...<br />NeuroFocushttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18367Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18366OSI Pharmaceuticals Announces That Tarceva® Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer<strong>OSI Pharmaceuticals Announces That Tarceva® Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenan...<br />OSI Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18366Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18365A.P. Pharma Receives FDA Complete Response Letter for APF530<strong>A.P. Pharma Receives FDA Complete Response Letter for APF530</strong><br /> A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical compan...<br />A.P. Pharma Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18365Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18364GenMark Diagnostics Files Registration Statement for Initial Public Offering<strong>GenMark Diagnostics Files Registration Statement for Initial Public Offering</strong><br /> GenMark Diagnostics, Inc. announced today that it ...<br />GenMark Diagnostics Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18364Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18363Evidence Suggests That Sleep is a Common Problem for People With a Wide Range of Neurological Conditions<strong>Evidence Suggests That Sleep is a Common Problem for People With a Wide Range of Neurological Conditions</strong><br />- UCB Supports World Sl...<br />UCBhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18363Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18356Teva Invites Public to Listen to Webcast of Investor Meeting<strong>Teva Invites Public to Listen to Webcast of Investor Meeting</strong><br /> Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) will host a live...<br />Teva Pharmaceutical Industries Ltd.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18356Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18355Phase 2 Data on Provectus’s PV-10 To Be Presented at the 2010 ASCO Scientific Program on June 4 - 8 in Chicago<strong>Phase 2 Data on Provectus’s PV-10 To Be Presented at the 2010 ASCO Scientific Program on June 4 - 8 in Chicago</strong><br /> Provectus Pharma...<br />Provectus Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18355Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18354New Amerinet Quality and Patient Safety Toolkits Provide Comprehensive Resource for Members<strong>New Amerinet Quality and Patient Safety Toolkits Provide Comprehensive Resource for Members</strong><br /> As part of the Amerinet Quality Sol...<br />Amerinethttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18354Sat, 19 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18341Rodman & Renshaw and BioSante Pharmaceuticals, Inc. Announce Fireside Chat on Women's Health<strong>Rodman &amp; Renshaw and BioSante Pharmaceuticals, Inc. Announce Fireside Chat on Women&apos;s Health</strong><br />Rodman &amp;amp; Renshaw(N...<br />Rodman &amp; Renshawhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18341Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18338Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum<strong>Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum</strong><br />- Groundbreaking partnerships foc...<br />ZS Associateshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18338Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18331Somaxon Announces FDA Approval of Silenor® (doxepin) for the Treatment of Insomnia<strong>Somaxon Announces FDA Approval of Silenor® (doxepin) for the Treatment of Insomnia</strong><br /> Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX)...<br />Somaxon Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18331Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18329PolyMedix Initiates Phase 1B Clinical Study With PMX-60056 To Reverse Low Molecular Weight Heparin<strong>PolyMedix Initiates Phase 1B Clinical Study With PMX-60056 To Reverse Low Molecular Weight Heparin</strong><br /> PolyMedix, Inc. (OTC BB: PYM...<br />PolyMedix Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18329Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18323Advaxis Research In ActA Shows Therapeutic Anti-Cancer Response<strong>Advaxis Research In ActA Shows Therapeutic Anti-Cancer Response</strong><br />Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria mo...<br />Advaxis Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18323Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18321Clinigen: acquisition of Foscavir from AstraZeneca<strong>Clinigen: acquisition of Foscavir from AstraZeneca</strong><br /> CLINIGEN: ACQUISITION OF FOSCAVIR (FOSCARNET SODIUM) FROM ASTRAZENECA...<br />Clinigen http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18321Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18320Global Partners Join Forces to Speed Development of New TB Drug Combinations<strong>Global Partners Join Forces to Speed Development of New TB Drug Combinations</strong><br />- FDA applauds effort to take years off development...<br />Global Alliance for TB Drug Developmenthttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18320Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18319Denmark's Odense University Hospital Works To Make Elekta VMAT Its Mainstream Radiation Therapy Technique<strong>Denmark&apos;s Odense University Hospital Works To Make Elekta VMAT Its Mainstream Radiation Therapy Technique</strong><br />- Faster arc-base...<br />Elektahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18319Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18317BioImagene Announces Integration with Market-Leading Anatomic Pathology Laboratory Information Systems<strong>BioImagene Announces Integration with Market-Leading Anatomic Pathology Laboratory Information Systems</strong><br />BioImagene, Inc., the le...<br />BioImagene Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18317Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18314CORRECTING and REPLACING Teva to Acquire ratiopharm<strong>CORRECTING and REPLACING Teva to Acquire ratiopharm</strong><br /> The third subhead should be: Company to Host Conference Call at 8:30 AM ET...<br />Teva Pharmaceutical Industries Ltd.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18314Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18312Targeted Sequencing in Maize Genome Utilizing a Novel Two-Stage Sequence Capture Method with NimbleGen Arrays and 454 Sequencing Systems<strong>Targeted Sequencing in Maize Genome Utilizing a Novel Two-Stage Sequence Capture Method with NimbleGen Arrays and 454 Sequencing Systems</stro...<br />Rochehttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18312Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18311First Publication of Data from Pivotal Clinical Trial for Medtronic Deep Brain Stimulation Therapy for Epilepsy Published Today in Epilepsia<strong>First Publication of Data from Pivotal Clinical Trial for Medtronic Deep Brain Stimulation Therapy for Epilepsy Published Today in Epilepsia</...<br />Medtronic Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18311Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18307International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment Epithelium (RPE) Derived from Human Parthenogenetic Stem Cells for Treatment of Retinal Diseases<strong>International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment Epithelium (RPE) Derived from Human Parthe...<br />International Stem Cell Corporationhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18307Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18306Nuvilex Announces Commencement of Production of Reme-Flu™<strong>Nuvilex Announces Commencement of Production of Reme-Flu™</strong><br /> Nuvilex, Inc. (OTC Bulletin Board: NVLX), announces today that Legacy...<br />Nuvilex Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18306Fri, 18 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18303Walgreens Reaches Agreement with USA Drug to Acquire Pharmacy Business and Certain Other Assets of Memphis-Area Ike’s and Super-D Drugstores<strong>Walgreens Reaches Agreement with USA Drug to Acquire Pharmacy Business and Certain Other Assets of Memphis-Area Ike’s and Super-D Drugstores</...<br />Walgreenshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18303Fri, 18 Mar 2010 01:00:00 GMT